SL STRATEGIES, LLC

Lobbying for SEQIRUS · pharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $45,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Budget/Appropriations

Fiscal Year 2026 HHS Appropriations bills

Health Issues

Policies impacting seasonal and pandemic influenza response

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.